214 related articles for article (PubMed ID: 9449637)
1. Corticotropin-releasing factor (CRF) agonists stimulate testosterone production in mouse leydig cells through CRF receptor-1.
Heinrich N; Meyer MR; Furkert J; Sasse A; Beyermann M; Bönigk W; Berger H
Endocrinology; 1998 Feb; 139(2):651-8. PubMed ID: 9449637
[TBL] [Abstract][Full Text] [Related]
2. Signaling properties of mouse and human corticotropin-releasing factor (CRF) receptors: decreased coupling efficiency of human type II CRF receptor.
Xiong Y; Xie LY; Abou-Samra AB
Endocrinology; 1995 May; 136(5):1828-34. PubMed ID: 7720627
[TBL] [Abstract][Full Text] [Related]
3. Structure and function of the ovine type 1 corticotropin releasing factor receptor (CRF1) and a carboxyl-terminal variant.
Myers DA; Trinh JV; Myers TR
Mol Cell Endocrinol; 1998 Sep; 144(1-2):21-35. PubMed ID: 9863624
[TBL] [Abstract][Full Text] [Related]
4. Regulation of corticotropin-releasing factor secretion from Leydig cells by serotonin.
Tinajero JC; Fabbri A; Dufau ML
Endocrinology; 1992 Apr; 130(4):1780-8. PubMed ID: 1312425
[TBL] [Abstract][Full Text] [Related]
5. Corticotropin-releasing factor is produced by rat Leydig cells and has a major local antireproductive role in the testis.
Fabbri A; Tinajero JC; Dufau ML
Endocrinology; 1990 Sep; 127(3):1541-3. PubMed ID: 2167219
[TBL] [Abstract][Full Text] [Related]
6. Constrained corticotropin-releasing factor (CRF) agonists and antagonists with i-(i+3) Glu-Xaa-DXbb-Lys bridges.
Koerber SC; Gulyas J; Lahrichi SL; Corrigan A; Craig AG; Rivier C; Vale W; Rivier J
J Med Chem; 1998 Dec; 41(25):5002-11. PubMed ID: 9836618
[TBL] [Abstract][Full Text] [Related]
7. 125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.
Grigoriadis DE; Liu XJ; Vaughn J; Palmer SF; True CD; Vale WW; Ling N; De Souza EB
Mol Pharmacol; 1996 Sep; 50(3):679-86. PubMed ID: 8794910
[TBL] [Abstract][Full Text] [Related]
8. Corticotropin-releasing hormone receptor expression and functional coupling in neonatal cardiac myocytes and AT-1 cells.
Heldwein KA; Redick DL; Rittenberg MB; Claycomb WC; Stenzel-Poore MP
Endocrinology; 1996 Sep; 137(9):3631-9. PubMed ID: 8756527
[TBL] [Abstract][Full Text] [Related]
9. Corticotropin-releasing factor receptor type 1 from Tupaia belangeri--cloning, functional expression and tissue distribution.
Palchaudhuri MR; Wille S; Mevenkamp G; Spiess J; Fuchs E; Dautzenberg FM
Eur J Biochem; 1998 Nov; 258(1):78-84. PubMed ID: 9851694
[TBL] [Abstract][Full Text] [Related]
10. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor.
Vaughan J; Donaldson C; Bittencourt J; Perrin MH; Lewis K; Sutton S; Chan R; Turnbull AV; Lovejoy D; Rivier C
Nature; 1995 Nov; 378(6554):287-92. PubMed ID: 7477349
[TBL] [Abstract][Full Text] [Related]
11. Regulation of corticotropin-releasing factor (CRF) receptors in the rat pituitary gland: effects of adrenalectomy on CRF receptors and corticotroph responses.
Wynn PC; Harwood JP; Catt KJ; Aguilera G
Endocrinology; 1985 Apr; 116(4):1653-9. PubMed ID: 2982594
[TBL] [Abstract][Full Text] [Related]
12. Effect of a dopamine agonist on luteinizing hormone receptors, cyclic AMP production and steroidogenesis in rat Leydig cells.
Dirami G; Cooke BA
Toxicol Appl Pharmacol; 1998 Jun; 150(2):393-401. PubMed ID: 9653071
[TBL] [Abstract][Full Text] [Related]
13. Corticotropin-releasing factor receptors and actions in rat Leydig cells.
Ulisse S; Fabbri A; Dufau ML
J Biol Chem; 1989 Feb; 264(4):2156-63. PubMed ID: 2464587
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoids inhibit corticotropin-releasing factor-induced production of adenosine 3',5'-monophosphate in cultured anterior pituitary cells.
Bilezikjian LM; Vale WW
Endocrinology; 1983 Aug; 113(2):657-62. PubMed ID: 6191964
[TBL] [Abstract][Full Text] [Related]
15. A novel mechanism of action of corticotropin releasing factor in rat Leydig cells.
Ulisse S; Fabbri A; Tinajero JC; Dufau ML
J Biol Chem; 1990 Feb; 265(4):1964-71. PubMed ID: 2153673
[TBL] [Abstract][Full Text] [Related]
16. Minimal-size, constrained corticotropin-releasing factor agonists with i-(i+3) Glu-Lys and Lys-Glu bridges.
Rivier J; Lahrichi SL; Gulyas J; Erchegyi J; Koerber SC; Craig AG; Corrigan A; Rivier C; Vale W
J Med Chem; 1998 Jul; 41(14):2614-20. PubMed ID: 9651165
[TBL] [Abstract][Full Text] [Related]
17. Involvement of cAMP-response element binding protein in corticotropin-releasing factor (CRF)-induced down-regulation of CRF receptor 1 gene expression in rat anterior pituitary cells.
Kasagi Y; Horiba N; Sakai K; Fukuda Y; Suda T
J Neuroendocrinol; 2002 Jul; 14(7):587-92. PubMed ID: 12121497
[TBL] [Abstract][Full Text] [Related]
18. Serotonergic inhibition of rat Leydig cell function by propranolol.
Tinajero JC; Fabbri A; Dufau ML
Endocrinology; 1993 Jul; 133(1):257-64. PubMed ID: 8391422
[TBL] [Abstract][Full Text] [Related]
19. A single-point slight alteration set as a tool for structure-activity relationship studies of ovine corticotropin releasing factor.
Beyermann M; Fechner K; Furkert J; Krause E; Bienert M
J Med Chem; 1996 Aug; 39(17):3324-30. PubMed ID: 8765516
[TBL] [Abstract][Full Text] [Related]
20. Corticotropin releasing factor (CRF) agonists with reduced amide bonds and Ser7 substitutions.
Cervini L; Theobald P; Corrigan A; Craig AG; Rivier C; Vale W; Rivier J
J Med Chem; 1999 Feb; 42(4):761-8. PubMed ID: 10052982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
